INSIDERTERMINAL

High-Impact Form 4 Intelligence

Real-time SEC insider trading data with advanced filtering. Free beta.

💬 Give Feedback

Total Buys (Filtered)

$40.0M

$39,977,138

Total Sells (Filtered)

$864K

$864,864

View Raw Line-Items

Live Feed: 2026-03-11

Timeline

Side

Size

All $1M+ $5M+ $10M+

Role

Ticker Search

Clear Clear Filters

Ticker	Company	Reporting Owner	Date	Value (USD)	Type	Form 4
DNLI S Denali Therapeutics Inc. Schuth Alexander O. • Officer • COFO and Secretary Discretionary Sell 2026-01-06 $284,097 View Form 4 →
DNLI	Denali Therapeutics Inc.	Schuth Alexander O. Officer • COFO and Secretary Discretionary Sell	2026-01-06	$284,097	S	Form 4
DNLI S Denali Therapeutics Inc. Watts Ryan J. • CEO Discretionary SellΔOwn -10.6% 2026-01-06 $580,767 View Form 4 →
DNLI	Denali Therapeutics Inc.	Watts Ryan J. CEO Discretionary SellΔOwn -10.6%	2026-01-06	$580,767	S	Form 4
DNLI P Denali Therapeutics Inc. BAKER BROS. ADVISORS LP • Director Discretionary Buy 2025-12-11 $39,977,138MEGAx2 View Form 4 →
DNLI	Denali Therapeutics Inc.	BAKER BROS. ADVISORS LP Director Discretionary Buy	2025-12-11	$39,977,138MEGAx2	P	Form 4